David R Doody, MS

Research Reports

Trend in TKI Use, Adherence, and Switching Patterns in Patients With CML: Before and After the Availability of Generic Imatinib

08/19/2020

&quot

Henry J Henk, PhD

Lena E Winestone, MD, MSHP

Jennifer J Wilkes, MD, MSCE

Pamela Morin, MBA

Shasank Chennupati, PharmD, MPH

David R Doody, MS

Eric J Chow, MD, MPH

Gary H Lyman, MD, MPH&quot

Abstract: The therapeutic landscape for chronic myeloid leukemia (CML) has evolved substantially over the past decade, most notably with the introduction of second- and third-generation tyrosine kinase inhibitors...

...

08/19/2020

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

September 18 ⁠–⁠ September 20

September 21 ⁠–⁠ September 22

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

See Full Calendar

David R Doody, MS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products